{"pending_diagnosis": "<b>DIAGNOSIS:</b>\n<span class=\"tg-spoiler\">Acute Intermittent Porphyria (AIP)</span>\n\n<b>THE SMOKING GUN:</b>\n<span class=\"tg-spoiler\">The patient's urine sample, collected on admission and left sitting on the counter under fluorescent lights, had gradually turned a deep, port-wine color overnight due to the oxidation of porphobilinogen (PBG) to porphobilin. Further history revealed the patient had taken a single dose of phenytoin (a known inducer) for a tremor a week prior, combined with the stressor of a severely carbohydrate-restricted diet (fasting state). Immediate testing confirmed massive elevations of Urinary Porphobilinogen (PBG) and Delta-Aminolevulinic Acid (ALA).</span>\n\n<b>PATHOPHYSIOLOGY:</b>\nAcute Intermittent Porphyria is an inherited metabolic disorder resulting from a deficiency in the enzyme Hydroxymethylbilane synthase (HMBS, formerly PBG deaminase), the third enzyme in the heme biosynthesis pathway. When triggered (by drugs, fasting, or hormones), the deficiency leads to the massive accumulation of neurotoxic heme precursors, specifically ALA and PBG, in the plasma and tissues.\n\nThis accumulation is thought to cause direct neurotoxicity, leading to the characteristic clinical syndrome:\n1.  <b>Visceral Neuropathy:</b> The severe, intractable abdominal pain (often mimicking an acute surgical abdomen but lacking physical findings).\n2.  <b>Autonomic Neuropathy:</b> Refractory tachycardia and hypertension are hallmarks.\n3.  <b>Central/Peripheral Neuropathy:</b> The rapidly ascending motor weakness (mimicking GBS but being a direct axonal process), seizures, and psychosis are due to the toxic effect of ALA/PBG on the central nervous system and peripheral nerves.\n\nTreatment is immediate infusion of high-dose intravenous glucose (to repress the pathway) and intravenous Hemin (Panhematin) to provide exogenous heme, which inhibits the enzyme ALA synthase, thereby halting the overproduction of toxic precursors. Delaying diagnosis can be fatal."}